Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03519191 · ClinicalTrials.gov registry record · NA

Healthy Relationships and Economic Pathways

A NA study, sponsored by Public Health Institute, California.

Terminated
Registry status
NA
Development phase
160
Enrollment target

NCT03519191: Clinical Trial NA study, sponsored by Public Health Institute, California.

NCT03519191 is a NA study that was terminated before completion, run by Public Health Institute, California. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03519191, a NA study, was terminated before completion, sponsored by Public Health Institute, California.

TERMINATED
Registry status
NA
Development phase
160 participants
Enrollment target

Study Summary

The California Adolescent Health Collaborative (CAHC) brings together multiple nonprofit organizations in California's Central Valley to implement the Healthy Relationships and Economic Pathways (H-REP) program, which aims to increase and promote healthy relationships and stability among youth between the ages of 14 and 24.

Primary Outcome

Baseline and 6 month follow-up surveys of participants will be conducted to assess impact of the intervention.

Interventions

  • BEHAVIORAL Healthy Relationships Education (HRE)
  • BEHAVIORAL HRE+Technology Bootcamp

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2017-06-01
Est. Completion 2018-07-01
Phase NA

Why NCT03519191 stopped before completion

NCT03519191 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Healthy Relationships Education (HRE) is the first listed.

NCT03519191 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03519191 about?

NCT03519191 is a clinical study titled "Healthy Relationships and Economic Pathways". The California Adolescent Health Collaborative (CAHC) brings together multiple nonprofit organizations in California's Central Valley to implement the Healthy Relationships and Economic Pathways (H-REP) program, which aims to increase and promote healthy relationships and stability among youth betwe...

What is the current status of trial NCT03519191?

This trial is currently terminated. It is a NA study. The enrollment target is 160 participants. The study started on 2017-06-01. Estimated completion is 2018-07-01.

What interventions are being tested in trial NCT03519191?

The interventions under investigation include: Healthy Relationships Education (HRE) (BEHAVIORAL), HRE+Technology Bootcamp (BEHAVIORAL).

Who is sponsoring clinical trial NCT03519191?

This trial is sponsored by Public Health Institute, California, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03519191's enrollment target sits among peer trials

160 628th of 2000 higher than 1,347 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03519191, the US trial registry maintained by the National Library of Medicine. NCT03519191 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.